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Abstract
Calton, Michele A. Ph. D. The University of Memphis. August, 2016. Compensatory
Respiratory Effects in Three Mouse Models of Developmental Cerebellar
Neuropathology during Exposure to and Recovery from Hypoxic and Hypercapnic
Challenges. Major Professor: Helen J. Sable, Ph. D.
Sudden unexplained death occurs in multiple populations. Significant evidence suggests
fatality was due to cardiorespiratory failure—likely in response to an exogenous stressor
which created an immediate hypercapnic (increased carbon dioxide) or hypoxic
(decreased oxygen) environment. Research into the mechanism(s) of failure has focused
on the brainstem (the classic cardiorespiratory control center) to no avail. Recently,
research has probed outside of the brainstem to identify structures that may play a
specific modulatory role during stressful conditions such as hypoxia and hypercapnia, for
example the cerebellum, which houses a pair of chemosensitive nuclei, the fastigial
nuclei (FN). As the Purkinje cells of the cerebellar vermis primarily innervate the FN,
and global cerebellar Purkinje cell loss inhibits the ability to respond to and recover from
mild hypoxic and hypercapnic stressors, the purpose of this study was to examine the
respiratory responses of multiple animal models of developmental cerebellar Purkinje cell
loss or dysfunction to hypoxic and hypercapnic stressors. It was hypothesized that
cerebellar Purkinje cell loss or dysfunction, regardless of extent, would result in a
reduced ability to respond to and recover from hypoxic and hypercapnic stressors.
Twelve male sibling mutant and wildtype mouse pairs from three strains (Fmr1, Lurcher,
and mdx) on three different genetic backgrounds (FVB, B6, and B10 respectively) were
exposed to multiple environmental stressors with periods of recovery in normal room air
in a whole body plethysmography system. Respiratory minute ventilation (MV) patterns
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were examined for changes in depth of breathing, breath frequency, and pausing between
breaths. Results of multiple mixed analyses of covariance indicated all animals responded
accordingly to the hypoxic and hypercapnic stressors by increasing their MV and
subsequently decreasing MV when allowed to recover in normal conditions. However,
regardless of strain, all mutant animals with cerebellar Purkinje cell loss or dysfunction
were slower to respond to stressors and revealed patterns of disordered breathing during
recovery. As cerebellar Purkinje cell loss or dysfunction and disordered breathing are
common in multiple populations at risk for sudden unexplained death, the precise role of
this neuropathology in the fatal event of sudden death victims should be further
investigated.
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Chapter 1: Introduction
Sudden Unexplained Death
Sudden unexplained death occurs in multiple populations including infants
(sudden infant death syndrome; SIDS), persons with epilepsy (sudden unexplained death
in epilepsy; SUDEP), children (sudden unexpected death in childhood; SUDC), and
adults (sudden unexpected death syndrome; SUDS) among others, and is a pervasive
problem that demands solving. In each of these cases, the victims appeared otherwise
healthy prior to the fatal event, are typically males, and are found in bed in the prone
position suggesting the distinct possibility that the fatal event has occurred during sleep
(Krous et al., 2004; Moon, Horne, & Hauck, 2007; NICHD, 2001). Diagnosis for each of
these disorders is exclusionary—no known cause of death is found even following a full
investigation and autopsy. Although the precise cause of death is not known across these
populations, there are often factors surrounding the deaths that have led many
investigators to conclude that cardiorespiratory failure occurred, culminating in the fatal
event. In addition to inherited vulnerabilities there are often interesting and unifying
neuropathological findings during histological examination of the brains of these victims
that suggest that there may be some commonality in the neural mechanisms contributing
to the vulnerability to these disorders.
Sudden infant death syndrome. SIDS is defined as the sudden, unexpected death of
an infant less than 1 year of age (Krous et al., 2004). SIDS risk vulnerability begins
shortly after birth, with few deaths occurring before one month of age, and peaks between
two and four months of age (Task Force on Sudden Infant Death Syndrome, 2005). The
principal explanation for the cause of SIDS, the triple-risk hypothesis, is multifactorial
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and states that in order to be identified as a SIDS victim three factors must converge: an
infant must have been at a critical period of development, have an unknown brain
abnormality, and been exposed to an exogenous stressor (Filiano & Kinney, 1994;
NICHD, 2001). Of the three factors involved in the triple-risk SIDS hypothesis,
exogenous stressors are unique in that researchers have been able to specifically identify
and educate the public about many of these stressors and subsequently reduce overall
SIDS deaths (Task Force on Sudden Infant Death Syndrome, 2005; Trachtenberg, Haas,
Kinney, Stanley, & Krous, 2012). Because the majority of SIDS deaths are thought to
occur during sleep, investigation of exogenous stressors is typically focused on stressful
sleeping conditions such as prone sleeping, or sleeping in soft bedding. These stressors
are known to either increase the infant’s immediate environmental levels of carbon
dioxide (CO2), or decrease available oxygen (O2), or both. Although the identification of
these exogenous stressors has, over two decades, reduced SIDS deaths, this condition
remains the leading cause of unexplained death in infants, which affirms the importance
of investigating and understanding the factors involved in SIDS vulnerability (Hauck &
Tanabe, 2008; Moon et al., 2007; NICHD, 2001; Trachtenberg et al., 2012).
Considerable evidence has suggested that SIDS occurs due to cardiorespiratory
failure. This is a reasonable conclusion as the stressors an infant may be exposed to cause
changes in the infant’s environmental levels of CO2 and O2 that challenge homeostatic
cardiac and respiratory mechanisms (e.g., sleeping in soft bedding, in the prone position,
etc…). Accordingly, research has focused on the cardiac and pulmonary musculature and
related brain systems involved in maintaining and regulating cardiorespiratory function.
Specific attention has been paid to pontine and medullary regions of the hindbrain as they
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have been established as control centers of normal, rhythmic respiratory and cardiac
output (Bianchi, Denavit-Saubie, & Champagnat, 1995). However, when these systems
are challenged (e.g.,, an increase in environmental CO2), additional central nervous
system (CNS) structures may be recruited to initiate and maintain appropriate
compensatory responses including increased respiration, increased heart rate,
repositioning, or even arousal. Thus, only recently has SIDS research extended into
investigation of neural systems outside of the brainstem into brain areas including the
cerebellum, which may modulate cardiorespiratory behavior under challenging or
stressful conditions (Harper, 2000).
The influence of the cerebellum in SIDS remains controversial with mixed
support for the hypothesis that this brain area plays a causal role in fatal events. For
example, while Cruz-Sanchez et al. (1997) found evidence of delayed cerebellar cortex
maturation in SIDS victims compared to controls, two additional reports found no
difference in cerebellar pathology between SIDS victims and controls (Kiessling et al.,
2013; Oehmichen, Wullen, Zilles, & Saternus, 1989). It is important to note in the two
non-supporting studies that the hypoxic conditions (e.g.,, pneumonia, asphyxia,
suffocation, carbon monoxide poisoning) that preceded many of the control deaths may
have contributed to the inability to find these differences as it has been shown repeatedly
that the infant cerebellum is especially vulnerable to hypoxic insult resulting in neuronal
death (Campanille et al., 2015, Huang & Castillo, 2008; Sarna & Hawkes, 2003).
Additionally, because the infant cerebellum is especially vulnerable to hypoxic insult,
these studies cannot differentiate the possibility that pre-existing cerebellar
neuropathology led to the fatal event from the competing hypothesis that episodes of

3

recurrent non-fatal hypoxia ultimately led to the fatal event, but also resulted in hypoxic
cerebellar damage. Because of likely variability in the many factors associated with
autopsy procedures it is also possible that the observed cerebellar hypoxic damage is tied
to variables related to the time interval between the fatal event and discovery, or possibly
the duration of the fatal event.
Sudden unexplained death in epilepsy. SUDEP is defined as unexplained death in
persons with epilepsy who (aside from seizures) appeared otherwise healthy before the
fatal event (Nashef, 1997). Deaths that can be attributed to secondary events that unfold
relative to ictal or postictal periods (e.g., hitting head, drowning, etc…) are not included
in a SUDEP diagnosis. Similar to SIDS, research has reported elevated risk for SUDEP in
males [with epilepsy], during sleep, with victims often found deceased in the early
morning hours in bed, and in the prone position (Kloster & Engelskjøn, 1999; Tomson,
Nashef, Hindocha, & Makoff, 2007). Additional risk factors for SUDEP include a history
of multiple monthly seizures, especially grand-mal seizures, middle age (20 – 40 years),
polytherapy with multiple antiepileptic drugs (AEDs), poor compliance with AEDs,
alcohol abuse, and intellectual disabilities including autism spectrum disorders (ASD)
which frequently present comorbidly with epilepsy (Hughes, 2009; Kiani et al., 2014;
Kloster & Engelskjøn, 1999). Hypotheses for the causes of SUDEP again emphasize the
likelihood of cardiorespiratory failure. Thus, investigation into the causes of SUDEP has
also focused extensively on the brainstem. It should be noted, however, that
neuropathological findings from SUDEP victims have suggested the necessity of
examining areas outside the brainstem in an effort to find causal influences on the
susceptibility for SUDEP.
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Cerebellar pathology including atrophy and Purkinje cell loss is common in both
patients with chronic epilepsy and victims of SUDEP (Botez, Attig, & Vezina, 1988;
Dam, 1987; Thom et al., 2015). Neuropathology of the cerebellum has often been
attributed to the reoccurrence of grand-mal seizures resulting in hypoxic brain injury, and
the use of antiepileptic drugs such as phenytoin has been shown to induce cerebellar cell
death (Botez et al., 1988; Brostoff, Birns, & McCrea, 2008; Dam, 1987; Eldridge, Stern,
Anainen, Koerber, & Wilder, 1983; Mclain, Martin, & Allen, 1980). However, even
without AEDs, clinical research indicates that cerebellar pathology is much more
common in patients with epilepsy and is related to seizure frequency (Bohnen, O’Brien,
Mullan, & So, 1998). Preclinical research also confirms a significant relationship
between seizures and neuronal loss in the cerebellum (Dam et al., 1984; Lomoio et al.,
2011). More specifically, increased severity and frequency of seizures results in
decreased cerebellar Purkinje cell density (Lomoio, Necchi, Mares, & Scherini, 2011).
Thus, cerebellar neuropathology can occur as a function of AED treatment or from the
repeated hypoxic episodes that accompany seizures.
Sudden unexplained death in childhood. SUDC is the unexplained death of a child
greater than 1 year of age extending up until 18 years of age (Hefti et al., 2016; Krous,
Chadwick, Crandall, & Nadeau-Manning, 2005). Similar to SIDS, these deaths primarily
occur in males during sleep and the victims are often found in the prone position, again
raising the possibility these deaths could have arisen from acute cardiorespiratory failure.
However, the phenomenon of SUDC has not been as extensively reported as SIDS and
thus knowledge is limited. Recent research on 151 referred children victims in San Diego
who perished from known causes, unknown causes, seizure-related causes, and SUDC
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has provided little insight into identifying unifying features of SUDC, but did reveal the
necessity of instituting a nationwide autopsy protocol to further the knowledge on SUDC
(Hefti et al., 2016).
Sudden Unexpected Death Syndrome. Unlike SIDS, SUDEP, and the more recently
described SUDC, SUDS has yet to be universally defined. The suggested windows of
time that characterize this sudden death syndrome have been variably described as above
the age of one year (Morentin, Suárez-Mier, & Aguilera, 2003), at least the age of two
years (Tungsanga & Sriboonlue, 1993), between the ages of 20-39 (Gervacio-Domingo,
Punzalan, Amarillo, & Dans, 2007), and young adult below the age of 40 (Elfawal,
2000). Further there is inconsistent use of terminology to describe this syndrome from the
addition of the term “nocturnal” to describe sudden unexpected nocturnal death
syndrome, to interchanging of the terms unexpected and unexplained, the omission of
both terms (unexpected and unexplained) altogether referring to it simply as sudden death
syndrome, or even the reference to “dead in bed syndrome” which is most frequently
used to describe sudden unexplained death in diabetes patients. Similar to SIDS, SUDEP,
and SUDC, most victims of SUDS are males found in bed following periods of sleep, and
complete autopsies and scene investigations yield no causal factors of the death (Elfawal,
2000; Furst, 1982; Gervacio-Domingo et al., 2007; Tungsanga & Sriboonlue, 1993). As
the most common cause of sudden deaths in young adults is the result of underlying
previously unknown cardiopathology (Corrado, Basso, & Thiene, 2001: Maron et al.,
1996), much of the research has been focused on genetic cardiovascular
pathophysiological risk factors for cardiac malfunction with respiratory risk factors rarely
investigated. As SIDS, SUDEP, SUDC, and SUDS each appear to have overlapping
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features with delineation arbitrarily made by age, it may be beneficial to model future
SUDS research after more extensively studied sudden death syndromes.
Eupneic and Stressed Breathing
Relaxed breathing (eupneic breathing) occurs during normally oxygenated
environmental conditions (21% oxygen, O2; 79% nitrogen, N2). Respiration is defined by
a number of accepted breathing characteristics that include minute ventilation (MV),
which is the amount of air breathed per minute. Minute ventilation is the mathematical
product of depth of breathing (tidal volume, TV) and frequency of breathing (f). The
frequency of breathing includes many components of respiration that all contribute to the
overall number of breath oscillations that can occur in one minute. One of these
components is TV; the larger the TV, the longer it may take to inspire, and thus the lower
the breath frequency could be (although the individual could simultaneously decrease
their inspiratory time mitigating the effect of this increase in TV on f). Another
interesting component of breath frequency is the end expiratory pause (EEP). The EEP is
the time period that occurs following exhalation and before inhalation. EEP is an
important breathing component in examining apnea, which is an extended EEP period
that varies slightly in definition depending on species and is an indicator of disordered
breathing and a reduced ability to compensate for rising blood CO2 levels (Feldman,
Mitchell, & Nattie, 2003; Nattie, 1999). During normal eupneic breathing EEP periods
consist of the minimal amount of time needed for the body to initiate and complete a
reversal in breathing function from exhalation to inhalation. It is widely accepted that
eupneic breathing is initiated and maintained by the pons and medullary structures of the
hindbrain (Feldman et al., 2003).

7

Stressed breathing occurs during challenging conditions of increased carbon
dioxide (hypercapnia) or decreased levels of oxygen (hypoxia). Under these challenges
compensatory respiratory patterns occur which increase overall MV via increases in TV,
f, or both as EEP periods decrease. Such compensatory changes are crucial to reducing
rising blood CO2 levels and increasing blood O2 levels. Typically as environmental CO2
increases, and thus blood levels of CO2 increase, the phenotypic compensatory response
is to increase breath frequency in an effort to expel the excess CO2. Shorter EEP periods
facilitate this effort by reducing the amount of time of CO2 accumulation in the body
before reintroducing O2 with inhalation. Hypoxia elicits a similar MV compensatory
response, but the increases are typically the result of amplified TVs in an effort to absorb
more available O2. Failure to respond appropriately to hypercapnic or hypoxic conditions
by increasing MV while maintaining or decreasing EEPs will accordingly result in an
increased body burden of CO2 with less available O2 for normal cellular functioning, with
potentially fatal consequences (Moore, Zwillich, Battaglia, Cotton, & Weil, 1976).
Because it is well established that brainstem structures are responsible for eupneic
breathing they have also served as the primary focus of investigation for failures of
stressed breathing. Given the apparently consistent involvement of the cerebellum in
multiple conditions involving sudden death it seems reasonable to expand the scope of
investigation outside of the traditionally implicated brainstem structures, into other brain
regions that have potential involvement in the regulation of stressed breathing.
Specifically, it is possible that the cerebellum, a structure massively innervated by the
pons and medullary brainstem regions, may play a modulatory role in cardiorespiratory
compensatory responses to environmental challenges.
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The Cerebellum
The cerebellum, also located in the hindbrain, has been well established as a
structure importantly involved in motor control (Fine, Ionita, & Lohr, 2002; Manto et al.,
2012). It is generally regarded that the cerebellum is responsible for the smooth, fluidlike coordination of voluntary movements as damage to this structure results in
uncoordinated and ataxic behaviors proportional to the level of damage (Richter et al.,
2005). For many years, research on the cerebellum has remained confined within the
realm of movement disorders. Recent research, however, has implicated this structure in
multiple functions outside of motor control including cognitive abilities and
cardiorespiratory modulation (Calton, Dickson, Harper, Goldowitz, & Mittleman, 2014;
Dickson et al., 2013; Dickson et al., 2010; Fatemi et al., 2012).
The cerebellum appears to play little to no role in cardiorespiratory functioning
during eupneic, relaxed breathing. Following complete cerebellectomy, eupneic patterns
of respiration and blood pressure are unchanged (Janssen, Lutherer, & Barnes, 1981; Xu
& Frazier, 1997; Xu, Owen, & Frazier, 1995; Xu, Taylor, Lee, & Frazier, 1993). The
cerebellum, however, does appear to play an important role in respiratory responding
under stressed conditions. Following complete cerebellectomy, respiration under hypoxic
conditions is impaired as indicated by decreased minute ventilation, TV and f (Xu et al.,
1995).
One potential explanation for the involvement of the cerebellum in cardiac and
respiratory responses in stressed conditions may involve one of the deep cerebellar nuclei
(DCN), the fastigial nuclei (FN). The FN has been identified as a chemosensitive area of
the brain, especially responsive to changes in blood levels of CO2 (Lutherer, Williams, &
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Everse, 1989; Xu & Frazier, 2002). The FN appears to play a modulatory role in both
cardiac and respiratory responses. In anesthetized cats, stimulation of the FN, but not the
other cerebellar nuclei resulted in increases in blood pressure (Achari & Downman,
1970). Further, low frequency electrical stimulation of the FN elicited an excitatory
respiratory response in cats, while high frequency stimulation resulted in an inhibition of
respiratory response with an increase in apneic episodes (Williams, Everse, & Lutherer,
1989).
Involvement of the FN in cardiac and respiratory modulation appears specific to
conditions of stress but not during eupneic breathing. Cell body lesions of this structure
exerted no effect on normal respiratory patterns or arterial blood pressure (Takahashi et
al., 1995). Under hypercapnic conditions, bilateral lesions of the FN resulted in an
attenuated respiratory response to increasing levels of CO2 (Xu & Frazier, 2000; Xu et
al., 1994) and when challenged with hypotension inducing drugs, heart rate and blood
pressure recovery were additionally and significantly impaired (Chen & Lutherer, 1985;
Chen, Williams, & Lutherer, 1994; Lutherer, Lutherer, Dormer, Janssen, & Barnes, 1983;
Williams, Robinson, & Lutherer, 1986).
The FN is primarily innervated by the Purkinje cells of the cerebellar vermis
(Kandel, 2000; Lu, Cao, Tokita, Heck, & Boughter, 2013; Zhang, Wang, & Zhu, 2016).
Purkinje cells comprise the sole output of the cerebellum and global loss of these cells
inhibit the ability of mice to recover appropriately from mild carbon dioxide exposure
(Calton et al., 2014; Calton, Howard, Harper, Goldowitz, & Mittleman, 2016). Further,
decreased cerebellar Purkinje cell number and density, especially in the vermis, is the
most frequent finding in persons diagnosed with ASD—a population with a high
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incidence of disordered breathing and a rate of mortality twice that of the general
population (Fatemi et al., 2012; Mouridsen, Brønnum-Hansen, Rich, & Isager, 2008;
Palmen, Engeland, Hof, & Schmitz, 2004; Pickett, Paculdo, Shavelle, & Strauss, 2006;
Shavelle, Strauss, & Pickett, 2001).
Additionally, the cerebellum is richly innervated by serotonin (5hydroxytryptophan; 5-HT) projections and although the precise role is evidently
complex, it has been suggested that 5-HT has a direct influence on deep cerebellar nuclei
firing (Saitow, Hirono, & Suzuki, 2013) which would include the FN. Although the
relationship between 5-HT and its effects in the cerebellum is incredibly complex both
temporally and spatially, excessive cerebellar 5-HT has been shown to impair timing
signals of the deep cerebellar nuclei (Saitow, Murano, & Suzuki, 2009) and blood
hyperserotonemia has been reported in ASD patients although the central effects remain
largely unknown (Whitaker-Azmitia, 2005). Further, in the Lurcher mouse, an animal
model of cerebellar Purkinje cell loss (the most common finding in ASD), increased
serotonin projections to the DCN have been observed which may suggest a rewiring of
the 5-HT network in these cerebella (LeMarec, Hebert, Amdiss, Botez, & Reader, 1998;
Strazielle, Lalonde, Riopel, Botez, & Reader, 1996). As serotonin is widely accepted as
integral in respiratory modulation, and neuropathophysiogical changes in the number or
distribution of 5-HT are suspected as influential in sudden unexplained death disordered
breathing patterns (Feldman et al., 2003; Harper & Kinney, 2010; Richerson &
Buchanan, 2011; Richter, Mazke, Wilken, & Ponimaskin, 2003), it may be necessary to
investigate this complex relationship between cerebellar neuropathology including
Purkinje cell loss or dysfunction, central serotonin, ASD symptomology, and breathing.
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Although, to date, there have been no systematic investigations into unexplained deaths
in the ASD population, mouse models with similar cerebellar neuropathology may help
shed light on the possibility of vulnerability to unexplained death in this group.
Animal Models of Developmental Cerebellar Neuropathology
Fmr1. Fragile mental retardation 1 (Fmr1) is a gene that encodes for fragile mental
retardation protein (FMRP; Hagerman & Hagerman, 2002). Increased expression of the
trinucleotide (CGG) segment of the Fmr1 gene results in silencing of the gene, which
further results in a stop to FMRP production—key deficits in Fragile X syndrome (FXS).
FXS is the most commonly inherited genetic cause of intellectual disability with up to
33% of those afflicted meeting criteria for diagnosis of ASD (Rogers, Wehner, &
Hagerman, 2001) and up to 25% being diagnosed with epilepsy (Berry-Kravis, 2002;
Wisniewski, Segan, Miezejeski, Sersen, & Rudelli, 1991).The Fmr1 mouse also exhibits
a silencing of the Fmr1 gene halting FMRP production and has been a widely used model
for investigating the physiological and behavioral effects of FXS and autism (Bakker et
al., 1994; Pietropaolo, Guilleminot, Martin, D’Amato, & Crusio, 2011).
Although there is little information about the likelihood of sudden death in the
FXS population, investigations of persons diagnosed with both epilepsy and severe
learning disorders revealed a risk for SUDEP three times the risk of patients with
epilepsy alone (Nashef, Fish, Garner, Sander, & Shorvon, 1995) suggesting that those
with both FXS and epilepsy also have an increased risk of sudden death. There is also
mixed evidence to suggest that sleep apnea, especially obstructive sleep apnea, in the
FXS population is elevated, although it has been proposed that facial abnormalities which
accompany FXS may contribute to this risk with further reports suggesting the actual risk
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is equal to the general population (Hagerman & Hagerman, 2002; Hersh & Saul, 2001;
Juncos et al., 2011; Kidd et al., 2014; Tirosh & Borochowitz, 1992;). More recent
evidence highlights this increased risk of apnea as being specific to persons diagnosed
with FXS and ataxia syndrome—a movement disorder that is seen in a subgroup of FXS
patients (Hamlin, Liu, Nguyen, Tassone, Zhang, & Hagerman, 2011). Interestingly, an
increased incidence of apnea raises the distinct possibility of hypoxia-related Purkinje
cell loss or damage, and there is evidence to support this relationship. Post-mortem
investigations of persons with FXS who died suddenly have revealed that these deaths
were likely the result of cardiorespiratory failure, and were associated with an increased
incidence of cerebellar Purkinje cell loss and vermal atrophy (Greco et al., 2011;
Sabaratnam, 2000). Whether the Fmr1 mouse experiences these apneic episodes remains
to be investigated.
Lurcher. The Lurcher mouse has been used extensively for research on olivoponto
cerebellar degeneration for over half a century. Litters of these mice are comprised of
wildtype mice, mutant mice heterozygous for the spontaneous mutation of the glutamate
receptor ionotropic delta 2 (GRID2) gene, and homozygous non-viable mice which die
shortly after birth (Vogel, Caston, Yuzaki, Mariani, 2005). The cerebellum of the mutant
mouse develops normally following birth but then exhibits the spontaneous GRID2
mutation which results in apoptosis of the cerebellar Purkinje cells beginning around
postnatal day (PND) 8 and culminating with nearly 100% loss by PND 28 (Caddy &
Biscoe, 1979; Zuo et al., 1997). Thus this mouse is a model of developmental cerebellar
neuropathology that has allowed researchers to identify the specific roles of Purkinje
cells.
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Investigation into the role of the cerebellum in modulating respiration events has
revealed that that loss of cerebellar Purkinje cells in the Lurcher mutant is without effect
on eupneic breathing, but causes deficits in initiating and maintaining appropriate
respiratory response patterns to environmental challenges. The Lurcher mutant mouse,
when exposed to minimally challenging levels of CO2 (2% and 4% CO2, 21% O2, N2 on
balance), was slow to initiate compensatory increases in minute ventilation which
persisted when re-introduced into normal room air conditions (0% CO2, 21% O2, 79%
N2). This abnormal breathing pattern during recovery consisted of large sporadic gasps
(large TVs) and extended apneic-like end-expiratory pause periods in the mutant mice,
but not the wildtypes (Calton et al., 2014; Calton et al., 2016).
mdx. The mdx mouse, another unique animal model of developmental cerebellar
Purkinje cell pathology, is a model of human Duchenne muscular dystrophy (DMD), a
progressive disease of muscle deterioration which affects approximately 1 in 7,250
human males (Romitti et al., 2015). The X-linked mutant mdx mouse exhibits a
spontaneous point-mutation in the DMD gene resulting in a loss of expression of the
protein dystrophin (Campbell, 1995; Sicinski et al., 1989). Loss of muscular dystrophin
in humans results in progressive myopathy and eventual early death due to
cardiorespiratory failure as a result of diaphragm deterioration (Gardner-Medwin &
Sharpies, 1989). In the mdx mouse this myopathology is less pronounced than in the
human condition with minimal reductions in life span, making this model more
appropriate for studying the effects of the central rather than peripheral loss of dystrophin
(Beastrom et al., 2011; Chamberlain, Metzger, Reyes, Townsend, & Faulkner, 2007).
However, the precise role of dystrophin in the CNS remains controversial.
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Within the CNS, dystrophin is most concentrated in the cerebellum and colocalized postsynaptically to cerebellar Purkinje cells (Lidov, Byers, Watkins & Kunkle,
1990). Further, the lack of dystrophin in the cerebellum results in decreased Purkinje cell
size, and reduced synaptic placticity as long-term depression of the Purkinje cells is
inhibited (Anderson, Head, & Morely, 2004). This reduction in synaptic plasticity is
thought to contribute to the cognitive deficits observed in boys with DMD, with nearly
30% classified as intellectually impaired with a mean intelligence quotient one standard
deviation below the corresponding normally developing population (Anderson, Head,
Rae, & Morely, 2002; Cotton, Voudouris, & Greenwood, 2001). Disordered breathing
within the DMD population, especially hypercapnic hypoventilation, is thought to be the
sole result of the diaphragm musculature deficit and has been shown to increase in
incidence along with increased muscular dystrophy (Ragette, Mellies, Schwake, Voit, &
Teschler, 2002). Mild diaphragmatic inflammation has been reported as early as three
months of age in mdx mice with accompanying minor decreases in minute ventilation
compared to controls (Huang et al., 2011). It remains to be examined, however, if
patterns of disordered breathing occur in mdx mice prior to measurable respiratory
musculature degeneration.
Purpose and Hypotheses
Experiment 1. The purpose of this study is to examine compensatory respiratory
responses in multiple models of cerebellar neuropathology with differing levels of
Purkinje cell loss or dysfunction to examine the specific significance of the Purkinje
cells. Given that mutant Lurcher mice, with 100% global Purkinje cell loss exhibit
significant respiratory response and recovery impairment during and following relatively
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minimally challenging levels of O2 and CO2 exposure (Calton et al., 2014), it seemed
reasonable that the next area of investigation should address the question of whether less
severe forms of cerebellar Purkinje cell neuropathology would elicit similar effects, thus
revealing the cerebellar Purkinje cells as a particularly key component of compensatory
respiratory responses. Thus, it was hypothesized that the contribution of the cerebellar
Purkinje cells to compensatory respiratory breathing patterns is so significant that the
level of loss or dysfunction would be irrelevant—no differences between cerebellar
mutant strains would emerge. It was further hypothesized that mutant Fmr1 and mdx
mice would exhibit similar patterns of respiratory compensatory deficits as mutant
Lurcher mice when environmentally challenged with decreased levels of O2, increased
levels of CO2, or both, when compared to their wildtype littermates. Specifically, within
the three groups of cerebellar mutant mice (Fmr1, Lurcher, and mdx), it was expected
that the mutants would respond to hypercapnic and hypoxic conditions less robustly than
their wildtype littermates and this would be evidenced by smaller increases in TV or f or
both during exposure. Further, the mutant genotypes within the three groups of mice
would show significant impairment in the ability to recover from hypercapnic and
hypoxic conditions in comparison to their wildtype littermates, which would be
evidenced by a diminished ability to reestablish baseline TV and f values in comparison
to the respiratory patterns of their wildtype counterparts. Finally, when breathing room
air at baseline, no significant differences between mutant and wildtype mice were
predicted.
Experiment 2. Following the finding of differences in breath frequency during
recovery in experiment 1, the purpose of this study was to examine, in depth, two
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components of breath frequency (TV and EEP) to pinpoint what may be driving the
observed differences. Thus the first hypothesis was, taking into account weight in
accordance with experiment 1, at baseline (room air) no differences between strain and
genotype would occur in either TV or EEP—the animals would have equivalent depths of
breathing and would all pause for an equal period of time between breaths. During
hypercapnic recovery conditions it was further hypothesized that differences in TV would
not occur—all animals would exhibit a progressive increase in TV in accordance with
increasingly challenging levels of hypercapnic recovery. However, it was further
hypothesized that during hypercapnic recovery conditions, differences observed in breath
frequency from experiment 1 would be a direct result of EEP durations among genotypes.
Specifically, mutant mice from each strain that exhibited reduced breath frequency in
experiment 1 would present prolonged EEP times compared to their wildtype littermates.
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Chapter 2: Experiment 1 Methodology
Animals
The experimental animals for this project consisted of 36 randomly selected littermate pairs (12 mutant and wildtype pairs for each of the three mouse strains: Fmr1,
Lurcher, and mdx) that will were aged PND 60 at the onset of testing. A single pair was
selected from each mating cage in order to avoid litter effects. Animals were bred and
maintained in the Animal Care Facility located in the Department of Psychology at the
University of Memphis. All animals were weaned at PND 25 +/- 3 days and siblinghoused in groups of 3-5 in ventilated polystyrene cages. Animals were continuously
maintained in a temperature controlled environment (21±1ºC) on a 12:12 light-dark cycle
(lights on at 0700) and given access to food and water ad libitum. Original breeders
(Fmr1, #004624, Fmr1 control #004828; Lurcher, #001046; mdx, #001801, mdx control
#000476) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). It
should be noted that each of these mutant mouse strains are on different genetic
backgrounds (Fmr1 = FVB, Lurcher = C57BL/6J, and mdx = C57BL/10J). While genetic
background has been shown to have a profound influence on behavioral phenotype
(Doetschman, 2009; Spencer et al., 2011), we additionally hypothesized that the effect of
genetic background is much smaller than the effects of cerebellar neuropathology on
stressed breathing. Thus, mice made on different genetic backgrounds were specifically
selected for these experiments. Although using multiple mutant mouse strains that share a
common genetic background is clearly a more popular approach with its own advantages
(Doetschman, 2009), the only way to determine if a phenotype is robust with respect to
genetic background is to compare across multiple backgrounds. All experiments were
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approved by the local Institutional Animal Care and Use Committee and were conducted
in accordance with the National Institutes of Health Guidelines for the Care and Use of
Laboratory Animals.
Breeding
Fmr1. The breeding procedures for Fmr1 mice consisted of two phases. The first
phase entailed the mating of male mice hemizygous for the Fmr1tm1Cgr targeted mutation
(FVB.129P2-Fmr1tm1Cgr/J) with wildtype control females (FVB.129P2-Pde6b+ Tyrcch

/AntJ). This breeding strategy produced F2 litters composed of heterozygous females

and wildtype males. Phase two consisted of mating F2 littermates to produce F3 litters of
experimental mice that included hemizygous and wildtype males. Genotypes of all mice
were confirmed at weaning with tail-snip polymerase chain reaction testing (PCR)
through an outside source (Transnetyx, Cordova, TN, USA).
Lurcher. The inbreeding of Lurcher mice entailed the filial pairing of a nonataxic female wildtype (WT; B6CBACa Aw-J/A-Grid2+) with a mutant ataxic male
heterozygous for the Lurcher spontaneous mutation (Lc/+; B6CBACa Aw-J/A-Grid2Lc).
This breeding strategy produced litters composed of both heterozygous Lc/+ and WT
mice. The Lc/+ mouse expresses this heterozygous Grid2 mutation resulting in nearly
100% developmental cerebellar Purkinje cell loss by PND 28 and this mutation is
phenotypically observable as early as PND 12 by ataxic gait, permitting the non-invasive
differentiation of Lc/+ mice from their non-ataxic WT littermates (Zuo et al., 1997).
mdx. Breeding the mdx strain of mice also consisted of two phases. The first
phase entailed mating original male mice hemizygous for the spontaneous Xchromosome linked muscular dystrophy mutation (C57BL/10ScSn-Dmdmdx/ J) with

19

female controls (C57BL/10ScSnJ) to produce F2 litters of heterozygous females and
wildtype males. Phase two consisted of mating F2 littermates to produce experimental F3
litters that consist of homozygous and wildtype males. Genotypes of all mice were
confirmed with tail-snip PCR at weaning through an outside source (Transnetyx,
Cordova, TN, USA).
Whole Body Plethysmography
Data were collected using a whole body plethysmography system (WBP; Emka
Technologies, Falls Church, VA, USA) in accordance with previously established
procedures (Calton et al., 2014). Briefly, animals were placed, unrestrained, into a
cylindrical plexiglass chamber (volume ≈ 450ml) while the percentages of environmental
O2, CO2, and N2 were manipulated by an in-house program using iOX2 software (Emka
Technologies; Falls Church, VA, USA). A transducer is mounted to the WBP which
converted pressure differentials in the chamber into electrical signals that were then
transmitted to and interpreted by the software. An outflow ventilation pump is connected
to the WBP to ensure a constant removal of exhaled CO2 at 0.8L/min in order to prevent
fatal accumulation of this gas.
Procedures
Mice were weighed prior to placement in the chamber and their weights (g)
recorded for analysis. Additionally, the experimental room temperature (21°C +/-1°C)
and humidity (25% +/-10%) were monitored daily to ensure stability throughout the
experiment. Using Emka Technologies iOX2 software (Falls Church, NC; USA; 2013),
three programs created in-house that have been previously published (Calton et al., 2014)
were used to assess the subjects’ respiratory responses at baseline (normal room air; 21%
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O2, 0% CO2 and 79% N2), and under conditions of hypercapnia and hypoxia. Mice were
randomly assigned to either the hypercapnia or hypoxia condition on PND 60—an age at
which cerebellar neuropathology has been observed in these strains of mice (Koekkoek et
al., 2005; Snow, Anderson, & Fry, 2014; Zuo et al., 1997), and the second condition
followed on PND 61. Each test day began with a 10-min habituation period, followed by
a 4-min exposure to baseline (Room Air) period with respective exposure to conditions of
hypercapnia or hypoxia to follow baseline.
Baseline. Following the 10-min habituation period, 4-min of baseline
measurements began. The dependent variables (DVs) tidal volume (TV, mL) and breath
frequency (f, breaths per minute; bpm) were recorded continuously under normal room
air conditions.
Hypoxia. The entire hypoxia program was 52 min in duration and consisted of
one beginning baseline (4-min) measurement as described above followed by four
sequential reductions in O2 (19%, 17%, 15%, 13% O2, N2 on balance) with a return to
normal room air between each successive challenge to minimize discomfort of the
animals. Each of the four challenges consisted of a 2-min fill period (the amount of time
necessary for the mass flow controllers to receive and execute the command to change
the gas content of the WBP and for the WBP to subsequently reach the desired
experimental gas percentages). The two minute fill period was followed by a 4-min
exposure period. Following the final challenge (13% O2) and subsequent return to room
air, the mice were removed from the chamber.
Hypercapnia. The hypercapnia program followed the same timeline as the
hypoxia program with the exception that following the baseline period, O2 remained
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constant at 21% and CO2 was successively increased (2%, 4%, 6%, 8% CO2, N2 balance).
Again, following the final challenge (8% CO2) and the return to room air, the mice were
removed from the chamber.
Variables and Data Analyses
The DVs in all conditions were TV and f. Breath sampling parameters for tidal
volume (the volume of air inhaled in one breath) and breath frequency were set at
approximately twice the normal, eupneic levels for mice to account for increased levels
of minute ventilation across the exposure programs (typical TV < 0.20 mL; typical f <
500 bpm; Crosfill & Widdicombe, 1961; Lorenz, 2002). Breaths that met the sampling
criteria were automatically averaged by the software in 10-s blocks across the duration of
the 52-minute long experiment. Breaths that did not meet the sampling criteria were
removed by the program automatically as movement artifacts.
Weights. Weights for the mice were recorded and analyzed with Strain (Fmr1,
Lurcher, and mdx) and Genotype (mutant and wildtype) as the between subjects factors.
Thus a 3 (Strain) x 2 (Genotype) analysis of variance (ANOVA) was performed to
identify any weight differences. If significant differences were found, then weight was
included in all subsequent analyses as a covariate. Using weight as a covariate in these
instances eliminated the possibility of this factor having an effect on the results as it has
previously been shown that body weight is tightly correlated with minute ventilation
(Crossfill & Widdicombe, 1961). Correlations between weight and TV were further
performed to identify the direction of the relationship between these variables.
Baseline. Because differences in body weight observed, the baselines collected
prior to the hypercapnia and hypoxia conditions were compared using repeated measures
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analyses of covariance (RMANCOVA), with separate analyses for each of the two DVs.
Strain and genotype again served as the between subjects factors, Time Block (24, tensecond time blocks) served as the within-subjects factor, and weight served as the
covariate. Thus, each analysis was a 3 (Strain) x 2 (Genotype) x 24 (Time Block) mixed
design.
Hypoxia and Hypercapnia. For each experimental program, separate
RMANCOVA analyses for each DV were performed. Strain and Genotype served as the
between-subjects factors. The within-subjects factors included four levels of Gas
(Hypoxia 19%, 17%, 15%, 13% O2, or Hypercapnia 2%, 4%, 6%, 8% CO2). Each gas
was subdivided into six, 2-minute Conditions (Fill, Exposure 1, Exposure 2, Refill,
Recovery 1, Recovery 2). The 2-min conditions were each further subdivided into 12, 10s Time Blocks in order to accurately track changes in the variables. Finally, weight
served as the covariate. Thus, each omnibus analysis was a 3 (Strain) x 2 (Genotype) x 4
(Gas) x 6 (Condition) x 12 (Time Block) mixed design. Depending on the results of the
Omnibus analyses, subsequent univariate analyses were used to analyze interaction
effects.
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Chapter 3: Experiment 2 Methodology
Animals
Hypercapnic data files for each of 36 experimental animals were run in
accordance with the procedures described below. The experimental groups consisted of
six randomly selected littermate pairs from experiment 1 from each of the three strains.
Procedures
Hypercapnic Data Files. The data files of each experimental mouse were
reanalyzed with new parameters using Emka Technologies iOX2 software (Falls Church,
NC; USA; 2013). The new paramaters eliminated the 10-second averaged time blocks
and instead investigated each individual breath.
Weights. The weights of the randomly chosen mice was recorded for analysis as a
covariate if necessary.
Baseline. The first 510 breaths from the new baseline file were used for analysis
of the breath frequency components TV and EEP. In order to examine the individual
components of breath frequency (TV and EEP) and to remove the confound of different
breathing rates on these analyses an equal number of breaths (510) was chosen from all
animals using previously described procedures (Calton et al., 2016).
Hypercapnic Recovery. The first 510 breaths from each of the four hypercapnic
recovery conditions (2%, 4%, 6%, 8%) in the new data file were used for analysis. These
breaths were extracted from the Recovery 1 and Recovery 2 periods described in
experiment 1.
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Variables and Data Analyses
The dependent variables in all conditions were TV and EEP. Breath sampling
parameters remained the same as experiment 1. Breaths that met the sampling criteria
were added to the data file for later analysis. The program automatically removed breaths
that did not meet the sampling criteria as movement artifacts.
Weights. Weights were again recorded for analysis with Strain (Fmr1, Lurcher,
and mdx) and Genotype (mutant and wildtype) as the between subjects factors. Thus a 3
(Strain) x 2 (Genotype) ANOVA was performed to identify any weight differences
among the randomly selected pairs from the three different mutant mouse strains and
determine the need for weight to be included in subsequent analyses as a covariate.
Baseline. Upon finding weight differences, the baseline collected prior to the
hypercapnic conditions was examined using RMANCOVA with separate analyses for
each of the two DVs. Strain and genotype served as the between subjects factors, while
Breath (510) served as the within-subjects factor, and weights served as the covariate.
Thus, each analysis was a 3 (Strain) x 2 (Genotype) x 510 (Breath) mixed design.
Hypercapnia Recovery. Two separate RMANCOVA analyses were performed
for each DV (TV and EEP). Strain and Genotype again served as the between-subjects
factors. The within-subjects factors included four levels of hypercapnia Recovery (from
2%, 4%, 6%, & 8% CO2). Within each level of recovery the first 510 breaths were
examined to identify moment-by-moment changes in breath frequency components.
Weights again served as the covariate. Thus, each omnibus analysis was a 3 (Strain) x 2
(Genotype) x 4 (Recovery) x 510 (Breaths) mixed design. Depending on the results of the
Omnibus analyses, additional univariate analyses were performed.
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Chapter 4: Experiment 1 Results
Weights
The results of a one-way ANOVA revealed there were significant differences in
weights between Fmr1, Lurcher, and mdx mice (Strain, F (2, 66) = 60.788, p < .001).
Post-hoc analyses revealed Lurcher mice (M = 20.271 g, SEM .402) weighed
significantly less than both Fmr1 mice (M = 25.033 g, SEM .402) and mdx mice (M =
26.183 g, SEM .402). Additionally, Pearson’s r revealed a significant positive correlation
between the weights of the animals and their depth of breathing, r (70) = .430, p < .001
(Figure 1). Thus, as body weight has been shown to be an important determinant of
minute ventilation all subsequent analyses included weight as a covariate in order to
remove the effect of weight as a factor in the results.
Strain Weight and TV Correlation
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Figure 1. Correlation between strain weight and tidal volume. Body weights and
corresponding averaged baseline TVs for each animal of each strain are plotted along
the centered regression line flanked by 95% confidence intervals.
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Baseline
Tidal Volume. During the baseline period, while breathing normal room air
(21% O2, 0% CO2, 79% N2), RMANCOVA revealed Fmr1, Lurcher, and mdx mice
differed in their depth of breathing (Figure 2; Strain, F (2, 65) = 5.04, p = .009) with
Lurcher mice demonstrating a much smaller TV (M = .165, SEM = .007) than mdx mice
(M = .199, SEM = .006). However, the depth of breathing in mutant mice and wildtype
mice was equivalent, (Genotype, F (1, 65) = 2.92, p = n.s.).
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Figure 2. Baseline tidal volume for both genotypes of each strain across time blocks.
Mean tidal volume (± SEM) for each of the 24, 10-second time blocks amongst all strains
and genotypes during normal room air (21% O2, 79%N2, 0% CO2).
Breath Frequency. A second RMANCOVA during the baseline period under
normal, room air conditions, revealed that the frequency of breathing among Fmr1,
Lurcher, and mdx mice, and among the mutant mice and wildtype mice was nonsignificantly different, (Figure 3; Strain, F (2, 65) = 2.19, p = n.s.; Genotype, F (1, 65) =
.26, p = n.s.). Additionally, there was no interaction effect, (Strain x Genotype F (2, 65) =
1.13, p = n.s.).
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Figure 3. Baseline breath frequency for both genotypes in each of the three strains across
time blocks. Mean breath frequency (± SEM) for each of the 24, 10-second time blocks
amongst all strains and genotypes during normal room air (21% O2, 79%N2, 0% CO2).
Hypoxia
Tidal Volume. The omnibus RMANCOVA revealed that exposure to decreased
levels of atmospheric O2 had the expected results; all mice displayed gradual reductions
in tidal volume as O2 decreased from 19% to 13% (Figure 4a; Gas F (3, 195) = 11.80, p =
< .001). Additionally regardless of O2 condition or time, Lurcher mice as a group
breathed more shallowly than the mdx and Fmr1 mice (Figure 4b; Strain F (2, 65) = 7.13,
p < .01).
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Figure 4. Main effects of gas and strain on tidal volume during hypoxia. Mean tidal
volume (± SEM) for each of the hypoxic gas exposure periods amongst all strains and
genotypes collapsed across conditions (a). Overall mean tidal volume (+/- SEM) for each
mouse strain (b). * represents p < .05.
As shown in Figure 5 (a, b, c), the RMANCOVA also identified genotypic differences by
strain in TV that were related to test condition (Fill, Exposure 1, Exposure 2, Refill,
Recovery 1, and Recovery 2; Strain x Genotype x Condition F (10, 325) = 3.11, p <
.001). Regardless of gas exposure, the mdx mutants, showed larger reductions in TV than
associated wildtype mice, that began to emerge during recovery 1 and intensified
throughout recovery 2 (Figure 5c; Recovery 1, Genotype, F (1, 21) = 3.82, p = .06;
Recovery 2, Genotype, F (1, 21) = 5.55, p = .028).
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O2 Tidal Volume per Strain by Genotype and Condition
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Figure 5. Recovery condition by strain by genotype effects on tidal volume during all
hypoxic gas challenges. Mean tidal volume (± SEM) collapsed across all hypoxic gas
exposures for Fmr1 mutant and wildtype mice (a), Lurcher mutant and wildtype mice
(b), and mdx mutant and wildtype mice (c). * represents p < .05, † represents p < .06
Breath Frequency. The omnibus RMANCOVA revealed two patterns of breath
frequency reduction associated with changes in O2 concentration and test condition. First,
all mice decreased their breath frequency as O2 concentration decreased (Figure 6a; Gas
F (3, 195) = 53.37, p = < .001). Second, breath frequency declined significantly
following exposure to reduced O2 concentrations, during chamber refill and recovery to
normal O2 levels (Figure 6b; Condition F (5, 325) = 20.68, p = < .001).
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Figure 6. Main effect of gas and condition on breath frequency during hypoxic
challenges. Overall mean breath frequency (± SEM) for each of the hypoxic gas
exposures (a), and for each of the hypoxic conditions (b).
Further, when considered across the hypoxia program, breath frequency in the mutant and
wildtype mice was equivalent (Data not shown; Genotype F (1, 65) = .05, p = n.s.).
However, strain differences did emerge as Fmr1 mice exhibited lower overall breath
frequency than Lurcher and mdx mice (Figure 7; Strain F (2, 65) = 3.43, p = .04).

31

O2 Breath Frequency by Strain
450

Breath Frequency (bpm)

425
400
375
350
325
*

300
275
250

M
dx

Lu
rc
he
r

Fm
r1

225

Group

Figure 7. Main effect of group on breath frequency during hypoxic challenges. Overall
mean breath frequency (± SEM) for each of the mouse strains across all hypoxic
exposures and conditions. * represents p < .05
Hypercapnia
Tidal Volume. The omnibus RMANCOVA results indicated that when exposed
to increasing levels of CO2, all mice exhibited typical response patterns, increasing their
depth of breathing as CO2 concentration increased (Figure 8; Gas F (3, 195) = 64.65, p =
< .001).
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Figure 8. Main effect of gas on tidal volume during hypercapnic gas exposures. Overall
mean tidal volume (± SEM) for all strains and genotypes.
Further, when considered across conditions all mice showed typical curvilinear patterns
of tidal volume response respective to condition (Figure 9).
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Figure 9. Main effect of condition on tidal volume during hypercapnia. Overall mean
tidal volume (± SEM) for each of the six conditions regardless of gas, strain, or genotype.
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In all mice and genotypes, the depth of breathing increased from the fill period to the
exposure periods and then gradually decreased as they transitioned from the refill period
and return to room air, to the final [recovery 2] condition (Figure 10; Condition F (5,
325) = 169.95, p = < .001).
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Figure 10. Mean tidal volume (± SEM) for each strain and each genotype across all of the
conditions.
Breath Frequency. A final omnibus RMANCOVA revealed a typical
compensatory pattern of breath frequency which decreased amongst all of the mice as
CO2 concentration increased (Figure 11a; Gas F (3, 195) = 21.93, p = < .001). All mice
also exhibited a typical curvilinear pattern of breath frequency response among the six
conditions. In all mice breath frequency increased from the fill period to exposure
periods, and then decreased following exposure through the final recovery period (Figure
11b, Condition F (5, 325) = 33.94, p = < .001; Strain F (2, 65) = .32, p = n.s.).
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Figure 11. Main effect of gas and condition on breath frequency during hypercapnia.
Overall mean breath frequency (± SEM) for each of the four hypercapnic gasses (a) and
for each of the six conditions (b).
The omnibus RMANCOVA also revealed significant genotypic differences that
occurred regardless of strain and in response to all changes in CO2 level. All mutant mice
exhibited reduced breath frequencies across the hypercapnia program compared to
wildtype mice (Genotype F (1, 65) = 4.45, p = .04). As shown in Figure 12 (a, b, c)
dependent on the condition, the breath frequency between the genotypes differed
significantly by strain (Strain x Genotype x Condition F (10, 330) = 2.21, p = .017).
Specifically, during the fill period Lurcher and mdx mutant mice were slower to respond
to increasing levels of CO2 compared to their wildtype littermates (Fill, Lurcher
Genotype F (1, 21) = 6.39, p = .02, Figure 12b; mdx Genotype x time F (11, 242) = 1.79,
p = .06, Figure 12c). During exposure 1 and exposure 2, mutant and wildtype mice in all
groups had equivalent breath frequency. Lurcher mutants were the first to fail to maintain
this increased level of breath frequency, beginning during refill to normal room air
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(Refill, Lurcher Genotype F (1, 21) = 6.96, p = .02). Once the WBP achieved normal
room air conditions, deficits in breath frequency occurred in all mutant mice. Thus,
mutant Fmr1, Lurcher and mdx mice all had significantly reduced breath frequencies
compared to their respective wildtype littermates during recovery 1 (Recovery 1,
Genotype F (1, 65) = 5.45, p = .023) and this deficit diminished throughout recovery 2
(Recovery 2, Genotype F (1, 65) = 3.89, p = .053).
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Figure 12. Effect of strain, genotype, and condition on breath frequency across
hypercapnia. Mean breath frequency (± SEM) for each hypercapnic condition for Fmr1
mice (a), Lurcher mice (b), and mdx mice (c). * represents p < .05, † represents p < .06.
Simple main effects tests revealed that across the two recovery conditions, Lurcher
mutants were the most impaired. Lurcher mutants had the largest decreases in breath
frequency compared to Fmr1 and mdx mutants (Figure 13, Strain x Condition F (2, 33) =
6.03, p = .01).
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Figure 13. Mean breath frequency (± SEM) for mutants of each strain during recovery 1
and recovery 2.
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Chapter 5: Experiment 2 Results
Weights
The results of a 3 x 2 between subjects ANOVA revealed a significant main effect
of strain, (Strain F (2, 30) = 37.06, p < .001). Specifically, Lurcher mice weighed
significantly less (M = 20.40 g, SEM = .526) than Fmr1 (M = 25.00 g, SEM = .526) and
mdx mice (M = 26.558 g, SEM = .526). However there was no difference between
genotypes, F (1, 30) = .787, p = .382, and there was no interaction between group and
genotype, F (2, 30) = 1.607, p = .217. Thus, as body weight has been shown to be an
important determinant of minute ventilation all subsequent analyses included weight as a
covariate to remove the effect of weight as a factor in the results.
Baseline
TV. Omnibus analysis revealed the depth of breathing (TV) across the 510
breaths during normal room air was significantly higher in mdx mice (M = .207, SEM =
.021) than Fmr1 (M = .184, SEM = .002) and Lurcher mice (M = .166, SEM = .020),
(Figure 14; Strain F (2, 29) = 3.63, p = .039). However, this difference did not extend
between the genotypes, (Genotype F (1, 29) = 1.04, p = n.s.). Further, there was no
interaction between group and genotype, (Group x Genotype F (2, 29) = 0.11, p = n.s.).
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Figure 14. Main effect of strain on tidal volume during baseline at normal room air (21%
O2, 79% N2, 0% CO2) in experiment 2. Mean tidal volume (± SEM) for each mouse strain
during baseline conditions across 510 breaths. * represents p < .05.
EEP. A second RMANCOVA revealed the time spent between exhalation and
inhalation (EEP) did not differ by strain, (Figure 15; Strain F (2, 29) = .11, p = n.s.), or
genotype, (Genotype F (1, 29) = .07, p = n.s.), nor was there an interaction between
group and genotype, (Group x Genotype F (2, 29) = .85, p = n.s.).
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Figure 15. Main effect of strain on EEP during baseline at normal room air (21% O2,
79% N2, 0% CO2) in experiment 2. Overall mean (± SEM) end expiratory pause (EEP)
for each of the strains.
Hypercapnic Recovery
TV. Omnibus RMANCOVA revealed that during recovery all animals exhibited
progressive increase in TV that corresponded to exposure to increasing concentrations of
CO2, (Figure 16; Recovery F (3, 90) = 4.73, p = .004).
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Figure 16. Main effect of recovery condition on tidal volume in experiment 2. Overall
mean tidal volume (± SEM) for each of the four hypercapnic recovery conditions. *
represents p < .05.
Further, mdx mice exhibited larger TVs overall (M = .210 ml, SEM = .016) than Fmr1 (M
= .180 ml, SEM = .014) and Lurcher mice (M = .192 ml, SEM = .002), (Figure 17; Strain
F (2, 29) = 4.04, p = .028). However, these differences did not extend to genotype,
(Genotype F (1, 29) = .14, p = n.s.), nor was there an interaction between strain and
genotype, (Strain x Genotype F (2, 29) = .28, p = n.s.).
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Figure 17. Main effect of strain on tidal volume in experiment 2. Overall mean tidal
volume (± SEM) for each of the three mouse strains collapsed across all hypercapnic
recovery conditions. * represents p < .05.
EEP. The omnibus RMANCOVA revealed all animals had significantly increased
their end expiratory pause durations between breaths corresponding to recovery from
increasingly challenging levels of hypercapnia, (Figure 18; Recovery F (3, 90) = 2.79, p
= .045), and this difference peaked at 6% recovery (M = 22.718 ms, SEM = 2.317).
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Figure 18. Main effect of recovery condition on EEP during recovery in experiment 2.
Mean EEP (± SEM) time for all animals at each of the four hypercapnic recovery
conditions. * represents p < .05.
Additionally, regardless of strain, there was no significant difference in the amount of
time the animals paused between breaths (EEP), (Strain F (2, 29) = .05, p = n.s.).
Interestingly, regardless of strain, genotype appeared to have an effect on the pause time,
with mutants pausing for longer periods of time between breaths (M = 23.680 ms, SEM =
.558) than wildtypes (M = 17.121 ms, SEM = .558), although these differences only
approached significance, (Figure 19; Genotype F (1, 29) = 3.96, p = .056). Analysis
further revealed there was no significant interaction between the strains of mice and the
genotypes, (Strain x Genotype F (2, 29) = .08, p = .926)
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Figure 19. Effect of genotype on EEP during hypercapnic recovery in experiment 2.
Overall mean EEP times (± SEM) for mutant and wildtype mice collapsed across all
hypercapnic recovery conditions. † represents p < .06.
.
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Chapter 6: Discussion
Baseline
Differences between the animals’ weights emerged and as expected revealed a
positive relationship in that body weight was coupled to TV. These results are reflective
of the typical relationship between body mass and respiratory function (Crossfill &
Widdicombe, 1961; Kleinman & Radford, 1964). Once weight was controlled for,
animals of all strains breathed at equivalent rates (f) and took an equal amount of time to
reverse their breath direction (EEP). These results further suggest that neither the
cerebellar neuropathology nor any potential muscle-related weakness in the genotypes of
each of these strains has an effect on normoxic ventilation in PND 60-61 mice.
Even after weight had been used as a covariate, Lurcher mice still exhibited much
smaller TVs than both Fmr1 and mdx mice. However, as body weight is an indirect
measure of assumed lung capacity, a more precise measure of lung capacity could be
used as a covariate and would likely moderate these differences. Additionally, as the
purpose of this investigation was to specifically identify the robustness of the effect of
cerebellar neuropathological differences in breathing in multiple strains across multiple
genetic backgrounds, this strain finding is ultimately unremarkable for the study at hand.
Hypoxia
The response to repeated exposures to challenging hypoxic conditions in mice of
all strains and genotypes resulted in a small decrease in MV (Figs. 4a, 6a). These results
are not entirely surprising as the response to mild hypoxia (O2 levels > 10%) is far less
robust than hypercapnia (Fong, 2010; Teppema & Dahan, 2010), and these same hypoxic
response patterns were previously observed in Lurcher mice (Calton et al., 2014). The
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overall decrease in MV across strains and conditions likely reflects the relatively brief
time designated between successive hypoxic challenges, and suggests that mice were not
given enough time to fully recover between these challenges.
Of unique interest were the response patterns of TV of mdx mutant mice across
the hypoxic conditions (Figure 5c). While both genotypes of the Fmr1 and Lurcher mice
maintained equivalent breathing patterns across all of the conditions (from fill to recovery
2), the mutant mdx mice revealed a distinct inability to maintain their depth of breathing,
with significant impairment by the time the animals reached recovery 2. That the mdx
mutant mice TVs did not differ from the wildtype mice during normoxia or during the
hypoxic fill and exposure conditions, and mdx mutant mice were able to attain and
maintain TV levels during hypercapnia nearly double those observed in the hypoxic
conditions (Figure 10), suggests this was not the result of an inability to achieve
equivalent TVs.
It is possible that the significant reduction in TV following hypoxia may be
indicative of fatigued diaphragm musculature in these animals as a result of dystrophin
deficient myopathy (Figure 5c). While slow diaphragmatic degeneration begins around
PND30 in these animals (Stedman et al., 1991), previous research has reported mixed
evidence for a respiratory deficit prior to the first year of age in mdx mice. In one report,
differences in MV between eight week old mdx mutant and wildtype animals were
present during both baseline and hypoxic exposures (Burns, Edge, O’Malley, &
O’Halloran, 2015). This possibility, however, appears unlikely as mdx mutants were fully
capable of maintaining much larger TVs that were equivalent to wildtype mice when
exposed to hypercapnic conditions (Figure 10c). Thus, a more parsimonious explanation

46

is that the impaired hypoxic recovery in mdx mice is related to peripheral chemoreceptor
deficits attenuating the response patterns of the animals to hypoxia (Mosquiera, Baby,
Lahiri, & Khurana, 2013).
It has been well established that respiratory response patterns to decreased
environmental O2 are far less robust than the response patterns to increased CO2 and the
control of these respiratory responses during development differs as well. Peripheral
chemoreceptors are responsible for managing the hypoxic ventilatory response until the
blood concentration of O2 drops significantly enough to achieve hypoxemia—a point at
which central chemoreceptors take over (Lagercrantz & Rohdin, 2008). In mice, it has
been shown that moderate hypoxemia occurs after 10 minutes of exposure to 7.9% O2 in
5 month old normal mice (Gonzalez, Kumar, Mulligan, Davis, & Saupe, 2004). Thus it is
probable the hypoxic conditions presented to the animals in the current study were not
challenging enough to create conditions for central chemoreception to take precedence
over peripheral receptors, likely because they were exposed to relatively mild hypoxic
conditions (19, 17, 15, and 13% O2, N2 balance) for a short period of time (4 minutes
each). This possibility is supported by the fact that the other two strains did not reveal
genotypic differences in minute ventilation, which if they had, would suggest central
involvement of the fastigial nuclei (Figure 5). It has further been reported that in 5-7
month old mdx mice the diminished response to hypoxia is directly attributed to
peripheral rather than central chemoreceptor deficits (Mosquiera et al., 2013).
Additionally, that mdx O2 blood levels are lower than controls during normal room air
conditions (Mosquiera et al., 2013) suggests it may be even more difficult to challenge
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these animals centrally with decreased O2 levels, as chronically low arterial O2 levels
weakens the response to hypoxic stimuli (Severinghaus, Bainton, & Carcelen, 1966).
Hypercapnia
As anticipated, the most profound differences in MV emerged during the
hypercapnia programs. First, as expected the TV and f response to hypercapnia in all
animals followed a distinct curvilinear pattern, which accompanied the transitions across
the six conditions (Figures 9, 11c). Animals increased their TV upon exposure to
hypercapnia and reduced their TV during recovery—a characteristic response pattern
(Moosavi et al., 2003; Sherwood, 1997). Further, the magnitude of change in TV
increased as the level of hypercapnic challenge and recovery increased (2% TV < 4% TV
< 6% TV < 8% TV; Figs 8, 16). Again, this was a typical response pattern as increased
levels of hypercapnia elicit an increased response in MV in an effort to expel
accumulating systemic CO2. However a different and abnormal pattern of hypercapnic
responses occurred for breath frequency that was apparent across genotype, regardless of
strain.
While the wildtype animals in all strains maintained nearly unchanged breath
frequency across all CO2 exposures, mutant mice consistently had lower breath
frequencies that were especially apparent during recovery (Figure 12). As mutants
simultaneously maintained TV (Figure 10) at wildtype levels, and TV and f are
components of minute ventilation, it is apparent that MV declined in all mutant mice.
Breath by breath analysis further indicated that there were differences in EEPs between
mutants and wildtype mice (Figure 19). Specifically, mutants had longer EEPs than
wildtype animals which obviously contributed to the observed reductions in breath
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frequency and MV in these animals. As the ability to increase MV is vital to effectively
reducing blood levels of CO2, it should be apparent that all mutants regardless of strain,
showed a compromised ability to reduce the body burden of CO2 and return to
homeostasis (Edelman, Epstein, Lahiri, & Cherniack, 1973) and this vulnerability
increases the level of concern for the likelihood of fatal CO2 accumulation in the mutant
mice across the three strains.
Relation to Previous Literature
Very little is known about disordered breathing patterns in the human FXS
population and much of it is controversial. It has been reported that in 1,295 children with
FXS or FXS carriers, persons with FXS reported an elevated incidence of sleep problems
including excessive daytime sleepiness which is often used as an indicator of
undiagnosed sleep apnea (Lavie, 1983; Kronk et al., 2010). Others who have directly
investigated apnea in FXS patients have either reported that it occurs only in a subset of
this population (FXS and ataxia syndrome) or that it only occurs in FXS patients with
facial abnormalities and results in episodes of obstructive sleep apnea (Hagerman &
Hagerman, 2002; Hamlin et al., 2011; Juncos et al., 2011; Kidd et al., 2014; Tirosh &
Borochowitz, 1992). In the current study Fmr1 mice exhibited patterns of disordered
breathing (including extended EEPs) following hypercapnia, which alludes to the
possibility that the associated human population may be vulnerable to apneic episodes
only when faced with a relatively mild environmental hypercapnic stressor. This
possibility deserves further investigation.
Multiple clinical investigations in patients with FXS have reported on two
cerebellar deficits; hypoplasia of the cerebellar vermis (Hoeft et al., 2010; Mostofsky et
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al., 1998) and cerebellar Purkinje cell loss (Greco et al., 2011). Pre-clinical studies using
magnetic resonance imaging and immunohistochemical analysis of the deep cerebellar
nuclei of 30 PND Fmr1 mice revealed a significant reduction in the volume of the deep
cerebellar nuclei, the main output of the cerebellum, compared to age- and sex-matched
wildtype mice (Ellegood, Pacy, Hampson, Lerch, & Henkelman, 2010). Additionally,
these authors noted a corresponding and significant reduction in the size of the fastigial
nuclei of these mice.
The FN is a chemosensitive area of the cerebellum in humans and animals that
modulates cardiorespiratory behavior when challenged and is especially responsive to
hypercapnic conditions (Gozal et al., 1994; Lutherer et al., 1989; Xu & Frazier, 2002).
Thus, it seems probable that a reduction in the volume of the FN would result in a
reduction in chemosensitivity, limiting an organism’s ability to respond to or recover
from increases in blood levels of CO2. Reductions in the size of the FN as well as all the
DCN appear to be a direct consequence of Purkinje cell loss as both Fmr1 mice and
Lurcher mutants have this combined neuropathology (Heckroth, 1994). Lurcher mice
have previously been shown to have a reduced ability to respond to and recover from
hypercapnic conditions, exhibiting signs of post-sigh apneic-like episodes with extended
EEP durations (Calton et al., 2014; Calton et al. 2016). These results were replicated in
the current study. As Fmr1 mutant mice also showed deficits in recovering from
hypercapnia as effectively as their wildtype littermates, the current study highlights the
importance of investigating challenged respiration, especially during hypercapnia, in
persons with FXS. Specifically, based on the current results it would be expected that

50

FXS individuals may show increased incidences of apneic-like episodes (i.e. extended
EEPs) after exposure to hypercapnia.
While extensive research has been performed on the dystrophin-deficient mdx
mouse, there is scant literature on the progression of CNS modulated respiratory deficits
that occur relative to well-described patterns of muscular [diaphragmatic] dystrophy in
these animals. The few findings describing respiratory patterns in these animals have
yielded mixed results. For example, a 20-minute, 10% O2 exposure period averaged over
one-minute intervals found attenuated MV in eight-week old mdx mice and controls
during both baseline and hypoxic exposure (Burns et al., 2016). While research on seven
month old mdx and control mice revealed no baseline (room air) differences in tidal
volume or breath frequency, but a diminished response during exposure to 7% CO2 in the
mutant animals (Gosselin, Barkley, Spencer, McCormick & Farkas, 2003). Further,
Gayraud et al. (2007) found no evidence for baseline or hypercapnic exposure differences
in averaged breath frequency or tidal volume in five month old mdx mice. That the
current findings further support evidence for no breathing differences in normoxia
between mdx mice and wildtype mice by PND 60 despite mild diaphragm myopathy, it is
quite possible these contradictory results may simply reflect the differing methodology
used and additionally highlights the need for comparable testing strategies.
Although the precise role of dystrophin in the CNS remains largely unknown, it is
widely believed that the learning disabilities associated with conditions such as
Duchenne’s muscular dystrophy are directly related to the central loss of dystrophin
(Cyrulnik & Hinton, 2008; Kim, Wu, & Black, 1995; Uchino et al., 1994). Dystrophin
has been found in the highest concentrations in the cerebellum, co-localized in cerebellar
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Purkinje cells, which suggests a critical role of dystrophin in Purkinje cell function. In
fact, evidence from dystrophin-deficient mdx mice has revealed evidence supporting a
reduction of postsynaptic γ-aminobutyric acid (GABAA) receptor clusters corresponding
with a reduction in inhibitory input in Purkinje cells in the cerebella of these mice
(Anderson et al., 2003). As reductions in Purkinje cell excitability would affect
downstream DCN function including the FN, it is probable the observed reduced CO2
sensitivity in mdx mice in the current study is an outcome related to dystrophin-mediated
synaptic connectivity alterations.
Implications and Future Research
As disordered breathing patterns would put a person, regardless of age, at
increased risk for ventilatory failure, and potentially subsequent sudden unexpected
death, it appears necessary to extend investigation into populations that exhibit both
cerebellar neuropathology and disordered breathing. Autism spectrum disorders are one
such condition with an increased incidence of breathing disorders and frequently reported
neuropathological changes to the cerebellum including Purkinje cell loss and DCN
volume variations (Fatemi et al., 2012; Kemper & Bauman, 1998). Although several
reports have described an increased risk of mortality in persons with ASD, especially in
persons with ASD and epilepsy (Hirvikoski et al., 2016; Mouridson et al., 2008), the
likelihood of sudden unexpected and / or unexplained death remains to be investigated in
this population. Further, as ASD is frequently diagnosed in persons with other diagnosed
neuropathological disorders, it would be advisable to expand the examination of sudden
unexpected or unexplained death to multiple clinical conditions.
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There are several neurodevelopmental disorders with high levels of comorbidity
with ASD, cerebellar neuropathology, and disordered breathing including Fragile-X,
Joubert, Prader-Willi, and Rett syndromes. These syndromes have documented cerebellar
vermal agenesis or dysgenesis (Joubert—Joubert, Eisenring, Preston, & Andermann,
1969), cerebellar hypoplasia (Prader-Willi–Titomanlio et al., 2006; Rett—Schaefer et al.,
1996) and cerebellar atrophy and Purkinje cell loss (FXS—Brunberg et al., 2002; Rett—
Murakami, Courchesne, Haas, Press, & Yeung-Courchesne, 1992). It has been commonly
reported that persons with these syndromes show an increased incidence of apnea during
the day as well as a heightened incidence of sleep apnea (Joubert—Wolfe, Lakadamyali,
& Mutlu, 2010; Prader-Willi—Festen et al., 2011; Holm, Cassidy, Whitman, & Butler,
1993; Rett—Weese-Mayer et al., 2006). It should also be noted that, in the syndromes
that have been studied most extensively, there is an elevated comorbidity of seizures and
epilepsy (FXS—Berry-Kravis, 2002; Prader-Willi—Vendrame et al., 2010; Zafeiriou,
Ververi, & Vargiami, 2007; Rett—Dolce, Ben-Zeev, Naidu, & Kossoff, 2013) as well as
evidence of increased prevalence of sudden death (FXS— Fryns, Moerman, Gilis,
d'Espallier, & Berghe, 1988; Prader-Willi—Einfeld et al., 2006; Rett—Fyfe, Leonard,
Dye, & Leonard, 1999). Thus, special emphasis should be placed on methodically
examining the relationships among conditions presenting with ASD symptomology,
cerebellar neuropathology (especially Purkinje cell loss or dysfunction and vermal
abnormalities), disordered breathing, and sudden death.
Epilepsy is another challenging neurological condition for researchers that
frequently presents with ASD symptomology and disordered breathing patterns as well as
increased vulnerability to sudden unexpected death. Cerebellar neuropathology,
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especially Purkinje cell loss, is common in persons with epilepsy and victims of SUDEP
although the precise cause is controversial (Botez et al., 1988; Dam, 1987; Thom et al.,
2015). While some researchers suggest the cause is related to repeated exposure to
hypoxia following multiple grand-mal seizures (Dam et al., 2007; Spielmeyer, 1930),
others suggest the cause may be related to AED use (Brostoff et al., 2008; Crooks,
Mitchell, & Thom, 2000; McLain et al., 1980; Ney, Lantos, Barr, & Schaul, 1994).
Regardless of the cause of the Purkinje cell loss in this population, however, the current
study indicates that loss or even dysfunction of these cells results in disordered breathing
patterns that may put someone at risk for sudden death. Thus, it is likely the cerebellar
Purkinje cell loss observed in SUDEP victims may not simply be a benign effect, but
rather may have contributed to the fatal event. Further, given substantial evidence of the
relationship between the cerebellar Purkinje cells and the FN—a modulator of
cardiorespiratory response patterns (Lutherer et al., 1989; Rector, Richard, & Harper,
2006; Xu & Frazier, 2002), and that treatments of epilepsy often include AEDs which
induce or exacerbate cerebellar damage including atrophy and Purkinje cell loss (Brostoff
et al., 2008; Crooks et al., 2000; Eldridge et al., 1983; Mclain et al., 1980), it can be
concluded these treatments may be placing patients at further risk for sudden unexpected
death and alternative approaches should be prioritized.
Dravet syndrome (DS) is an extreme form of myoclonic epilepsy that typically
presents in infancy or early childhood and is associated with a significant rate of
premature mortality and SUDEP (Genton, Velizarova, & Dravet, 2011; Kalume, 2013).
Intellectual disabilities and ASD are present in up to 98% of children and adults with
Dravet syndrome (Berkvens et al., 2015; Li et al., 2011). Although DS is generally drug
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resistant, clinical symptom treatment often includes the use of multiple AEDs. Given the
low response of DS to AEDs, the families of DS patients often resort to popular social
treatments including adopting a ketogenic diet or using cannabinoid oil although
scientific evidence of their efficacy is absent (Scichilone, Yarraguntla, Charalambides,
Harney, & Butler, 2016). Clinical investigation has described recurrent cerebellar atrophy
and Purkinje cell loss in a mixed population that included both living and deceased
persons with epilepsy (including SUDEP victims) with or without DS (Catarino et al.,
2011). Further, preclinical evidence of impaired cerebellar Purkinje cell firing is thought
to cause ataxia associated with Dravet syndrome (Catterall, Kalume, & Oakley, 2010).
Although direct evidence of disordered breathing in this subset of epilepsy patients
remains to be described, it is commonly inferred that this group is particularly at risk for
cardiorespiratory deficits—a key factor involved in SUDEP susceptibility (Kalume,
2013; Nashef, Hindocha, & Makoff, 2007). Considering the documented frequency of
cerebellar neuropathology (specifically Purkinje cell loss) and the increased risk for
SUDEP in the DS population, assumptions of disordered breathing patterns appear
justified and should be verified in future investigations. Further it seems reasonable to
conclude the pathologies reported in DS patients may be cyclical—repeated severe
seizures result in hypoxic cerebellar Purkinje cell death, which would perpetuate
intellectual disability or ASD symptoms and further increase the risk for disordered
breathing. Disordered breathing patterns would, in sequence, increase the risk for hypoxic
cerebellar neuronal death, and the cycle would repeat until the ultimate sudden demise of
a challenged patient by cardiorespiratory failure. Thus, research in DS may be
complicated and these relationships deserve further investigation.
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Serotonin is another interesting component of breathing worth consideration.
Serotonin, particularly important during development, exerts effects on cardiorespiratory
behavior in a manner that is not entirely understood and neuropathological changes in the
number or distribution of 5-HT containing neurons can directly influence this activity
(Richter et al., 2003). The brainstems of SIDS victims consistently reveal 5-HT
abnormalities including decreased 5-HT receptor binding in the medulla (Panigraphy et
al., 2000). The Lurcher mouse, along with global cerebellar Purkinje cell loss, exhibits an
extensive increase in 5-HT projections to the deep cerebellar nuclei, including the
fastigial nuclei (LeMarec et al., 1998; Strazielle et al., 1996). As cerebellar Purkinje cell
loss is the most commonly reported deficit in patients with ASD (Fatemi et al., 2012) and
research reports ASD patients have pathological changes in platelet 5-HT which includes
abnormally low levels during early development and abnormally high levels in
adolescence and especially adulthood (Chugani, Muzik, Chakraborty, Mangner, &
Chugani, 1998), investigation on central neuropathological 5-HT changes in this
population should be pursued.
Medicinal treatment options for some of the symptoms of ASDs, FXS, and
epilepsy includes the use of selective serotonin reuptake inhibitors (SSRIs), especially in
early childhood (Albano, Cupello, Mainardi, Scarrone, & Favale, 2006; Aman, Lam, &
Van Bourgondien, 2005; Berry-Kravis & Potanos, 2004) suggesting hypofunction of
serotonin in these disorders. Interestingly, the use of SSRIs in clinical research has
revealed these medications may be an effective method for modulating disordered
breathing patterns including apnea (Kraiczi, Hedner, Dahlof, Ejnell, & Carlson, 1999).
Further, a decreased hypercapnic ventilatory response has been reported in rats with
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decreased cerebral 5-HT and SSRIs have been shown to augment this response (Hodges,
Echert, Puissant, & Mouradian, 2013). Although how 5-HT dysfunction or dysregulation
contributes to disordered breathing patterns remains unknown, it is evident this
neurochemical system is significantly complex and future investigations should include
examination of central serotonergic neuropathology in populations with disordered
breathing. Further, given that persons with FXS, ASD, and Duchenne’s exhibit apparent
pathological serotonergic changes, 5-HT exerts a direct effect on cardiorespiratory
behavior, and the current results suggest disordered breathing occurs during recovery
from mild hypercapnic challenges in these groups, these complex relationships with the
potential risk for sudden death should be considered.
It is important to address that although each of the aforementioned disorders may
have additional neurological or physiological deficits, in the literature there is a clear
pattern of relationship within these disorders with cerebellar neuropathology, autism
spectrum disorder symptomology, disordered breathing, and sudden unexpected death
incidence greater than the general population. As there are multiple categories of sudden
death typically demarcated by developmental stage, special attention should be directed
towards those who exhibit these apparently clustered risk factors regardless of age.
Further, the consistent reporting of this tetra-factorial risk provides additional credence to
the necessity of developing unified nationwide post-mortem sudden death protocols to
further the knowledge base on these syndromes.
Conclusion
The purpose of this study was to investigate three components (TV, f, and EEP) of
direct and indirect influence on minute ventilation under conditions of normoxia,
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hypoxia, and hypercapnia in three mutant mouse strains that displayed a variety of
developmental cerebellar neuropathologies in comparison to their wildtype littermates.
The goal of these studies was to determine if these heterogeneous, cerebellar
neuropathological differences contribute to stressed breathing, and thus contribute to an
increased risk for sudden death. Throughout normoxia and hypoxic conditions mutant
and wildtype mice maintained similar levels of minute ventilation and exhibited similar
respiratory response patterns. However, in response to hypercapnic challenges, mutant
mice of all strains revealed an impaired ability to appropriately recover by failing to
maintain their breath frequency. This failure was a result of an increase in the pause time
between breaths—a sign of an increased incidence of apnea. As apnea reduces an
individual’s ability to appropriately re-establish homeostatic blood O2 and CO2 levels,
these results suggest not only substantial cerebellar Purkinje cell loss, but even mild
dysfunction or dysregulation of the cerebellar Purkinje cells, may contribute to a failed
respiratory response. Further, as cardiorespiratory failure is believed to be the cause of
death in multiple sudden unexplained death events, it is possible the neuropathological
findings reported in the cerebella of these victims did not occur as a result of the death,
but rather preceded and contributed to these deaths. This possibility deserves further
attention.
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